Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 2,231,201 |
|
|||||
| News | - | ||||||
| Day High | 11.83 | Low High |
|||||
| Day Low | 11.015 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Vir Biotechnology Inc | VIR | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.75 | -6.26% | 11.23 | 16:23:32 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 11.76 | 11.015 | 11.83 | 11.23 | 11.98 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 20,500 | 2,231,201 | US$ 11.38 | US$ 25,389,236 | - | 7.61 - 27.48 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:13:33 | 39 | US$ 11.65 | USD |
Vir Biotechnology Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.52B | 135.03M | - | 86.18M | -615.06M | -4.55 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Vir Biotechnology News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VIR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 10.41 | 13.09 | 10.19 | 11.77 | 1,577,778 | 0.82 | 7.88% |
| 1 Month | 9.51 | 13.09 | 9.355 | 10.93 | 981,110 | 1.72 | 18.09% |
| 3 Months | 10.47 | 13.09 | 7.61 | 9.87 | 952,492 | 0.76 | 7.26% |
| 6 Months | 9.54 | 13.09 | 7.61 | 10.02 | 1,059,581 | 1.69 | 17.71% |
| 1 Year | 25.94 | 27.48 | 7.61 | 11.55 | 1,206,743 | -14.71 | -56.71% |
| 3 Years | 45.41 | 58.00 | 7.61 | 24.13 | 1,160,310 | -34.18 | -75.27% |
| 5 Years | 16.15 | 141.01 | 7.61 | 30.28 | 1,130,808 | -4.92 | -30.46% |
Vir Biotechnology Description
| Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions. The company's pipeline consists of product candidates targeting hepatitis B virus, or HBV, influenza A, human immunodeficiency virus, or HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue and license revenue. |
